GLP2 T

Sold by case = 10 vials

Tirzepatide

For Research Use Only. Not for Human or Veterinary Consumption.

Commonly marketed as Tirzepatide, this is a synthetic peptide agonist targeting both GLP-1 and GIP receptors, studied in laboratory research for its effects on metabolic regulation and glucose homeostasis. Researchers utilize Tirzepatide to investigate dual incretin receptor activation and its impact on appetite, insulin secretion, and energy balance in experimental models. This compound supports advanced studies into novel approaches for metabolic and endocrine signaling pathways.

This product is intended exclusively for qualified laboratory research. Not approved for therapeutic, diagnostic, or human use.

Mechanism of Action

• Dual receptor activation: mimics both GIP and GLP‑1 hormones, enhancing glucose-dependent insulin secretion, suppressing glucagon, and reducing appetite.
• Biased agonism: shows stronger GIP receptor affinity and preferential signaling at GLP‑1 receptors, leading to improved insulin sensitivity and metabolic effects  .
• Additional benefits: slows gastric emptying, increases satiety, and raises adiponectin levels, aiding both weight loss and glycemic regulation